Skip to Main Content

Author Details

Sergio V Perrone
El Cruce Hospital by Florencio Varela, Lezica Cardiovascular Institute
1988
53
21
PMIDPaper TitleJournal TitlePublished Year
36196060Association of time-to-intravenous furosemide with mortality in acute heart failure: data from REPORT-HF.Eur J Heart Fail2023
37547170Dengue Myocarditis: A Case Report and Major Review.Glob Heart2023
36974770Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF.Eur J Heart Fail2023
36660017Emerging concepts in heart failure management and treatment: focus on current guideline-directed medical therapy for heart failure with reduced ejection fraction.Drugs Context2023
36660016Emerging concepts in heart failure management and treatment: focus on tachycardia-induced cardiomyopathy.Drugs Context2023
36660015Emerging concepts in heart failure management and treatment: focus on point-of-care ultrasound in cardiogenic shock.Drugs Context2023
36660012Emerging concepts in heart failure management and treatment: focus on vericiguat.Drugs Context2023
36660011Emerging concepts in heart failure management and treatment: circulatory support with extracorporeal membrane oxygenation (ECMO).Drugs Context2023
34516969A global perspective of racial differences and outcomes in patients presenting with acute heart failure.Am Heart J2022
35429091Quality of life assessed 6â¿¿months after hospitalisation for acute heart failure: an analysis from REPORT-HF (international REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure).Eur J Heart Fail2022
35393622Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction.Eur Heart J2022
36471037Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved.Nat Med2022
35064730Regional differences in precipitating factors of hospitalization for acute heart failure: insights from the REPORT-HF registry.Eur J Heart Fail2022
33175585Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status: Results From the EMPEROR-Reduced Trial.Circulation2021
33839078Global Differences in Burden and Treatment of Ischemic Heart Disease in Acute Heart Failure: REPORT-HF.JACC Heart Fail2021
34449189Empagliflozin in Heart Failure with a Preserved Ejection Fraction.N Engl J Med2021
32710857Correction to: Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study.Lancet Glob Health2020
31726194Prior Heart Failure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared With Valsartan in HFpEF.J Am Coll Cardiol2020
31913404Global Differences in Characteristics, Precipitants, and Initial Management of Patients Presenting With Acute Heart Failure.JAMA Cardiol2020
31360228Chagas Disease and Heart Failure: An Expanding Issue Worldwide.Eur Cardiol2019
29980595Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial.Circ Heart Fail2018
25754836International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registry.Eur J Heart Fail2015
21624855[Update in the diagnosis and treatment of pulmonary hypertension].Medicina (B Aires)2011
20172342South American Heart Transplantation Registry of patients receiving everolimus in their immunosuppressive regimens.Transplant Proc2010
19700774Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials.Eur Heart J2009
17234522A wireless pressure sensor for monitoring pulmonary artery pressure in advanced heart failure: initial experience.J Heart Lung Transplant2007
18091519A lower incidence of cytomegalovirus infection in de novo heart transplant recipients randomized to everolimus.Transplantation2007
16647515Recommendations for use of everolimus after heart transplantation: results from a Latin-American Consensus Meeting.Transplant Proc2006
16904548Detection of transplant coronary artery disease using multidetector computed tomography with adaptative multisegment reconstruction.J Am Coll Cardiol2006
16098385Calcium sensitizer agents: a new class of inotropic agents in the treatment of decompensated heart failure.Int J Cardiol2005
16211166I Latin American Guidelines for the Assessment and Management of Decompensated Heart Failure.Arq Bras Cardiol2005
15350455Orthotopic heart transplantation in elderly patients: a 10-year experience at a single center.Transplant Proc2004
12559210Pharmacotherapeutic approaches for decompensated heart failure: a role for the calcium sensitiser, levosimendan?Eur J Heart Fail2003
12687804Which patients with congestive heart failure may benefit from biventricular pacing?Pacing Clin Electrophysiol2003
11872746Tyrosine kinase c-Src constitutes a bridge between cystic fibrosis transmembrane regulator channel failure and MUC1 overexpression in cystic fibrosis.J Biol Chem2002
12411899Right atrial size and tricuspid regurgitation severity predict mortality or transplantation in primary pulmonary hypertension.J Am Soc Echocardiogr2002
11173318Borjeson-Forssman-Lehmann syndrome and dilated cardiomyopathy: a previously unreported association.Can J Cardiol2001
11777165Biventricular resynchronization as an unusual bridge to transplantation: acute effects.Tex Heart Inst J2001
11077230Early diagnosis of recurrence of Trypanosoma cruzi infection by polymerase chain reaction after heart transplantation of a chronic Chagas' heart disease patient.J Heart Lung Transplant2000
11292127Primary pulmonary artery sarcoma resembling chronic thromboembolic pulmonary disease.Eur Respir J2000
11436709[Severe dilatation of the pulmonary artery and extrinsic compression of the left coronary arterial trunk in primary pulmonary hypertension].Medicina (B Aires)2000
10578365Value of pre-heart-transplant psychological evaluation: long-term follow-up.Transplant Proc1999
9625017Anti-skeletal muscle glycolipid antibodies in human heart transplantation as predictors of acute rejection: comparison with other risk factors.Transplantation1998
9137213Heart rate is a marker of amiodarone mortality reduction in severe heart failure. The GESICA-GEMA Investigators. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina-Grupo de Estudios Multicéntricos en Argentina.J Am Coll Cardiol1997
8889987Identification of programmed cell death (apoptosis) in situ by means of specific labeling of nuclear DNA fragments in heart biopsy samples during acute rejection episodes.J Heart Lung Transplant1996
8917262Amrinone stimulation test: ability to predict improvement in left ventricular ejection fraction after coronary bypass surgery in patients with poor baseline left ventricular function.J Am Coll Cardiol1996
8962290Osteoporosis following heart transplantation.Transplant Proc1996
8989129Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators.Circulation1996
8818435Coagulation and fibrinolytic parameters in patients with pulmonary hypertension.Clin Cardiol1996
8755818Anti-skeletal muscle glycolipid antibodies in human heart transplantation as markers of acute rejection. Correlation with endomyocardial biopsy.Transplantation1996
  • 1 - 50 of 53

Recommended Authors

Duke University Medical Center, NC Duke Clinical Research Institute
Career Start Year 2017
Number of shared co-authors 0
University of Florida Gainesville
Career Start Year 2015
Number of shared co-authors 0
University of Florida
Career Start Year 2014
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2011
Number of shared co-authors 0
Duke University Medical Center, Duke Clinical Research Institute
Career Start Year 2010
Number of shared co-authors 4
University of Florida
Career Start Year 2009
Number of shared co-authors 0
Ronald Reagan university of california los angeles Medical Center
Career Start Year 2008
Number of shared co-authors 0
The Ohio State University Wexner Medical Center
Career Start Year 2006
Number of shared co-authors 3
Ronald Reagan university of california los angeles Medical Center Los Angeles CA.
Career Start Year 2001
Number of shared co-authors 1
Rabin Medical Center, Tel Aviv University
Career Start Year 2000
Number of shared co-authors 1
Yale School of Medicine
Career Start Year 1999
Number of shared co-authors 10
Hospital of the University of Pennsylvania
Career Start Year 1998
Number of shared co-authors 3
Mayo Clinic
Career Start Year 1997
Number of shared co-authors 0
Duke University Hospital
Career Start Year 1997
Number of shared co-authors 2
University of Florida
Career Start Year 1997
Number of shared co-authors 1
Emory University Division of Cardiology Atlanta Georgia USA.
Career Start Year 1996
Number of shared co-authors 1
Duke University School of Medicine
Career Start Year 1992
Number of shared co-authors 15
Toronto General Hospital, University of Toronto
Career Start Year 1991
Number of shared co-authors 0
Cardiology University of California San Francisco (UCSF)
Career Start Year 1991
Number of shared co-authors 17
INSERM UMR-S , Universite de Paris Cite
Career Start Year 1989
Number of shared co-authors 15
Tufts Medical Center
Career Start Year 1989
Number of shared co-authors 10
Mission Hospital
Career Start Year 1989
Number of shared co-authors 7
Ronald Reagan university of california los angeles Medical Center
Career Start Year 1989
Number of shared co-authors 4
The Texas Heart Institute
Career Start Year 1987
Number of shared co-authors 5
University of Pennsylvania Perelman School of Medicine
Career Start Year 1987
Number of shared co-authors 10
Department of Medicine Morehouse School of Medicine Atlanta GE.
Career Start Year 1985
Number of shared co-authors 8
Gregorio Maranon University Hospital
Career Start Year 1980
Number of shared co-authors 3
Vanderbilt University Medical Center
Career Start Year 1980
Number of shared co-authors 15
Northwestern University Feinberg School of Medicine
Career Start Year 1972
Number of shared co-authors 11
Mayo Clinic College of Medicine and Science
Career Start Year 1969
Number of shared co-authors 7

Collaborators

National and Kapodistrian University of Athens, Attikon University Hospital
Co-authored papers 14
Duke-NUS Medical School
Co-authored papers 13
British Heart Foundation Centre of Research Excellence, University of Glasgow
Co-authored papers 11
Novartis Pharma AG
Co-authored papers 10
University of Bergen
Co-authored papers 10
Linkoping University
Co-authored papers 10
Novartis Pharma AG
Co-authored papers 10
University Hospital Wurzburg
Co-authored papers 10
University and University Hospital Wurzburg
Co-authored papers 10
Novartis Pharma
Co-authored papers 9
Alexandria University
Co-authored papers 9
Vanderbilt University School of Medicine
Co-authored papers 9
Co-authored papers 4
Co-authored papers 2
Thomas Jefferson University
Co-authored papers 2
Co-authored papers 2
University of Wisconsin
Co-authored papers 1
University of Toronto
Co-authored papers 1
Charite University Medicine, Berlin Institute of Health (BIH)
Co-authored papers 1
Novartis Ireland Ltd
Co-authored papers 1
Bluhm Cardiovascular Institute, Northwestern University Feingerg School of Medicine
Co-authored papers 1
Duke University
Co-authored papers 1
Vanderbilt University Medical Center
Co-authored papers 1
Co-authored papers 1
Massachusetts General Hospital
Co-authored papers 1
Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases
Co-authored papers 1
The Ohio State University
Co-authored papers 1
University of Missouri-Kansas City School of Medicine
Co-authored papers 1
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 1
Saint Joseph Hospital, Paris-Sorbonne University
Co-authored papers 1